BeOne Medicines
ONC
#700
Rank
ยฃ24.91 B
Marketcap
ยฃ225.19
Share price
-2.62%
Change (1 day)
61.27%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2025 (TTM): ยฃ0.39

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is ยฃ0.48. In 2024 the company made an earnings per share (EPS) of -ยฃ4.64.

EPS history for BeOne Medicines from 2015 to 2025

Annual EPS

Year EPS Change
2025 (TTM)ยฃ0.39-108.47%
2024-ยฃ4.64
2022-ยฃ14.5228.21%
2021-ยฃ11.32-19.96%
2020-ยฃ14.1520.81%
2019-ยฃ11.7131.52%
2018-ยฃ8.90417.57%
2017-ยฃ1.72-37.16%
2016-ยฃ2.74158.95%
2015-ยฃ1.06

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
-ยฃ0.71-246.15%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-ยฃ0.18-136.92%๐Ÿ‡บ๐Ÿ‡ธ USA